Literature DB >> 15095120

Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode.

K Schlottmann1, F Klebl, N Zorger, S Feuerbach, J Schölmerich.   

Abstract

BACKGROUND AND AIMS: Contrast harmonic imaging significantly increases the detectability of liver lesions which are invisible on conventional B-mode sonography. With the introduction of contrast agents, which can be visualized at low mechanical index (low-MI), continuous real time observation of liver lesions under contrast conditions is possible. We addressed the question whether contrast-enhanced sonography allows for intervention of hepatic lesions impossible to detect on conventional B-mode imaging. PATIENTS AND METHODS: We evaluated twelve patients with hepatic tumors or abscesses, which could not be analyzed and punctured under fundamental B-mode guidance. The ultrasound contrast agent BRI was used for detection of the hepatic lesions under contrast harmonic imaging (CHI) conditions with phase inversion at low-MI.
RESULTS: In eleven out of twelve patients interventions under CHI conditions were successful, as proven by histological, microbiological or tumor marker analysis. The puncture needles were visible in all cases. With an algorithm for optimizing the puncture conditions at low-MI CHI the biopsies can be performed in two steps.
CONCLUSIONS: Our results show that biopsies of liver lesions under real-time continuous CHI at low-MI are feasible.

Entities:  

Mesh:

Year:  2004        PMID: 15095120     DOI: 10.1055/s-2004-812712

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  9 in total

Review 1.  Diagnostic biopsy for hepatocellular carcinoma in cirrhosis: useful, necessary, dangerous, or academic sport?

Authors:  J Schölmerich; D Schacherer
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

Review 2.  Fortuitously discovered liver lesions.

Authors:  Christoph F Dietrich; Malay Sharma; Robert N Gibson; Dagmar Schreiber-Dietrich; Christian Jenssen
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

3.  Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound.

Authors:  Soon Ho Yoon; Kyoung Ho Lee; So Yeon Kim; Young Hoon Kim; Jee Hyun Kim; Sang Hyub Lee; Tae Kyoung Kim
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

4.  The benefit of contrast-enhanced ultrasound in biopsies for focal liver lesions: a retrospective study of 820 cases.

Authors:  Jia-Xin Huang; Cai-Gou Shi; Yan-Fen Xu; Juan Fu; Yuan Zhong; Long-Zhong Liu; Xiao-Qing Pei
Journal:  Eur Radiol       Date:  2022-07-26       Impact factor: 7.034

5.  Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance - A Multi-Center Study.

Authors:  Giampiero Francica; Maria Franca Meloni; Ilario de Sio; Fulvia Terracciano; Eugenio Caturelli; Laura Riccardi; Paola Roselli; Maddalena Diana Iadevaia; Mariano Scaglione; Giovanni Lenna; Jason Chiang; Maurizio Pompili
Journal:  Ultraschall Med       Date:  2017-12-12       Impact factor: 6.548

6.  Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound-preliminary experience.

Authors:  Sasan Partovi; Ziang Lu; Rivka Kessner; Alice Yu; Yasmine Ahmed; Indravadan J Patel; Dean A Nakamoto; Nami Azar
Journal:  J Gastrointest Oncol       Date:  2017-12

Review 7.  International guidelines for contrast-enhanced ultrasonography: ultrasound imaging in the new millennium.

Authors:  Christian Pállson Nolsøe; Torben Lorentzen
Journal:  Ultrasonography       Date:  2015-12-23

8.  Contrast enhancement for ultrasound-guided interventions: when to use it and what to expect?

Authors:  Zeno Sparchez; Tudor Mocan; Rares Craciun; Mihaela Sparchez; Christian Nolsøe
Journal:  Ultrasonography       Date:  2021-12-09

Review 9.  Contemporary role of liver biopsy in hepatocellular carcinoma.

Authors:  Zeno Sparchez; Tudor Mocan
Journal:  World J Hepatol       Date:  2018-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.